Mamuti Alimujiang, Tulading Aliya, Zhang Yun-Fei, Azhati Yilizhati, Tuersunmaimaiti Abudusalamu, Maimaiti Maiwulanjiang, Lv Chun-Hui, Wu Jing, Yao Gang, Aierken Amina, Tuxun Tuerhongjiang
Department of Liver & Laparoscopic Surgery, Center of Digestive and Vascular Surgery, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China.
Center of Organ Transplantation, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China.
World J Hepatol. 2024 Dec 27;16(12):1493-1504. doi: 10.4254/wjh.v16.i12.1493.
Liver transplantation (LT) has demonstrated favorable efficacy in managing end-stage alveolar echinococcosis. Nevertheless, the current research focal points and advancement trends remain ambiguous.
To map the research landscape to underscore critical areas of focus, influential studies, and future directions of LT for echinococcosis treatment.
Publications on LT for echinococcosis treatment published between 1900 and 2023 were searched in the Web of Science database and analyzed using bibliometrics.
A total of 14 countries/regions, 75 institutions, and 499 authors have published research articles, with China, Turkey, and France being the three most productive countries. The four institutions with the most contributions were Sichuan University, Xinjiang Medical University, the University de Franche Comte, and Inonu University. The three authors who contributed the most were Wen Hao, Wang Wentao, and Bresson Hadni Solange. The four most common keywords were alveolar echinococcosis, LT, liver resection and autotransplantation, and echinococcosis multilocularies.
Our study found that the treatment of complications after LT for echinococcosis treatment and the preoperative surgical plan based on the anatomical relationship between the lesion and the blood vessel are early research hotspots. Recent research focuses on the treatment of complications after liver resection and autotransplantation, especially vascular complications.
肝移植（LT）在终末期肺泡型棘球蚴病的治疗中已显示出良好疗效。然而，目前的研究重点和进展趋势仍不明确。
描绘研究概况，以突出肝移植治疗棘球蚴病的关键重点领域、有影响力的研究及未来方向。
在科学网数据库中检索1900年至2023年间发表的关于肝移植治疗棘球蚴病的文献，并采用文献计量学进行分析。
共有14个国家/地区、75个机构和499位作者发表了研究文章，中国、土耳其和法国是发文量最多的三个国家。贡献最大的四个机构是四川大学、新疆医科大学、弗朗什孔泰大学和伊诺努大学。贡献最大的三位作者是文浩、王文涛和布雷松·哈尼·索朗热。最常见的四个关键词是肺泡型棘球蚴病、肝移植、肝切除及自体移植和多房棘球蚴病。
我们的研究发现，肝移植治疗棘球蚴病后并发症的处理以及基于病变与血管解剖关系的术前手术方案是早期研究热点。近期研究集中在肝切除及自体移植后并发症的处理，尤其是血管并发症。
